Allergic Disorders

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 10/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1222 times

106 Allergic Disorders

Allergic Disease: Allergic Rhinits, Insect Stings, Drug Allergy

Epidemiology

The prevalence of allergic disorders, including the incidence of anaphylaxis, has been increasing worldwide in the last few decades and is a topic of intensive study.1,2 Features of Western lifestyles, such as changes in infant diets, widespread use of antibiotics, smaller family size, and cleaner child care, are believed to reduce stimulatory antigenic exposure in an individual’s early years. This has led to an environment in which the immune system is dominated by a persistent allergy-prone system.3

Allergic Rhinitis

It is estimated that up to 42% of Americans suffer from some form of allergic rhinitis at any one time,4 and it has been shown to have a strong correlation with asthma. In recent studies, nearly 40% of adults with allergic rhinitis were also found to have asthma, and 80% of asthmatics demonstrated signs of rhinitis.

Drug Allergy

A drug allergy is defined as an immune-mediated adverse response to a drug. An adverse drug reaction is defined as a noxious, unintended, or undesired response to a drug taken at a normal dose for the prevention, diagnosis, or treatment of a disease,6 and a drug side effect is an expected and known (adverse) effect of taking the drug that is not the intended therapeutic outcome. Although the true frequency is unknown, drug allergy is thought to account for approximately one third of adverse drug reactions.7 Adverse drug reactions affect 10% to 20% of hospitalized patients and more than 7% of the general population.

Pathophysiology

The immune system protects the host by distinguishing self from nonself; it tolerates the former but attacks the latter.8,9 Allergy, allergic diseases, and hypersensitivity reactions arise when our immune system reacts inappropriately to allergens with resultant harm to the host.1,2,10,11 For allergic diseases to occur, predisposed individuals need to first be exposed to an allergen through a process called sensitization.

The term atopy is used to describe the propensity in affected patients to produce IgE in response to otherwise innocuous environmental allergens. Atopic patients have higher serum levels of IgE antibody and a propensity for the development of one or more atopic diseases (e.g., allergic asthma, allergic rhinoconjunctivitis, atopic dermatitis, urticaria, angioedema).

Hypersensitivity reactions are mechanistically divided into four types of reactions according to the Gell and Combs classification system (Box 106.1). The immediate hypersensitivity reaction (type I), which is mediated by IgE, serves as the classic model of the immune response to allergen. On initial exposure to allergen, T helper 2 (TH2) cells are activated, which results in the production of an array of cytokines that exert their effects on the T cells themselves, B cells, and antigen-presenting cells. IgE is elaborated and attached to the high-affinity Fc receptor on the surface of mast cells and basophils. Fixation of allergen-specific IgE leads to a series of cellular and molecular changes that prime these cells for future exposure. On reexposure, allergen cross-links the cell-bound IgE on the surface of mast cells and basophils, thereby setting in motion a complex cascade of events that lead to the release of preformed mediators such as histamine, lipid mediators, and cytokines and subsequent activation of various inflammatory pathways. These mediators and products of secondary inflammatory pathways cause adherence and chemotaxis of inflammatory cells, increased capillary permeability, vasodilation, smooth muscle contraction, and sensory nerve stimulation. A few allergen molecules can thus cause the release of a large number of mediator molecules in a designed amplification response. Examples of type I hypersensitivity reactions include allergic rhinitis, allergic asthma, urticaria, angioedema, and anaphylaxis.

See Box 106.1, Types of Hypersensitivity, online at www.expertconsult.com.

Allergens are typically carbohydrate or protein molecules (or parts of a larger molecule) that elicit an immune response.10

The inflammation that occurs in allergy is divided into three temporal phases.10 Early-phase reactions occur within minutes of exposure and are considered immediate type I hypersensitivity reactions. Late-phase reactions typically occur within 2 to 6 hours and peak 6 to 9 hours after exposure. This response is thought to be due to newly synthesized cytokines, growth factors, and chemokines, which were released more slowly than the preformed mediators primarily responsible for the early-phase reaction. This reaction often involves airway narrowing and hypersecretion of mucus in the lungs, in addition to the erythema, warmth, and pain experienced in the skin. In some individuals there is no clinical distinction between the early and late phases. Chronic allergic inflammation is the final phase in the inflammatory process. It occurs after persistent or repetitive exposure to specific allergens and results in tissue remodeling and structural changes in affected cells. Chronic allergic inflammation can further increase epithelial injury, mucus production, and thickening of airway walls.

The majority of serious sting-related reactions are caused by insects belonging to the order Hymenoptera (yellow jackets, hornets, honeybees, wasps, and fire ants).5 Their venom contains histamine, dopamine, various peptides, and protein enzymes that are either vasoactive or can elicit significant allergic reactions (IgE mediated).

Presenting Signs and Symptoms

Differential Diagnosis and Medical Decision Making

Allergic Rhinitis

Box 106.2 lists other diagnostic considerations in patients with symptoms that may mimic allergic rhinitis.12 Patients older than 20 years should be investigated for nonallergic causes (e.g., polyps). Atopic patients with severely inflamed conjunctivae, lids, and periorbital structures should raise the possibility of atopic keratoconjunctivitis (Fig. 106.1) and vernal keratoconjunctivitis (Fig. 106.2). These two types of chronic allergic conjunctivitis have the potential to cause corneal erosions and ulcers leading to vision loss and should be managed in consultation with an ophthalmologist.

image

Fig. 106.1 Atopic keratoconjunctivitis.

(From Baba I. Red eye—first aid at the primary level. Community Eye Health 2005;18:70–72.)

image

Fig. 106.2 Vernal keratoconjunctivitis.

Notice the lumpy appearance on the conjunctivae.

(From Yorston D, Zondervan M. Red eye picture quiz. Community Eye Health 2005;18:72–78.)

Typically, no diagnostic tests need to be performed in the ED. Specific IgE serum assays such as the radioallergosorbent test (RAST), enzyme-linked immunosorbent assay (ELISA), skin prick test, and nasal smears are usually performed by allergists.

Drug Allergy

Understanding the involvement of an immunologic mechanism in drug allergy may help physicians in determining whether a reaction represents an adverse drug reaction or a true drug allergy. For example, the stomach discomfort that may result from taking nonsteroidal antiinflammatory drugs (NSAIDs) is an adverse drug event and not a drug allergy. Factors that favor a drug allergy include a history of previous sensitization (the drug was taken before) and typical allergic symptoms (urticaria, angioedema, wheezing).

Common entities to consider are infection (viral exanthem, mononucleosis, Rocky Mountain spotted fever, syphilis, cellulitis, sepsis), insect bite, pityriasis rosea, serum sickness, vasculitides, contact dermatitis, fixed drug eruption, and drug hypersensitivity syndrome.

Diagnosis of an adverse drug reaction relies on a careful history and thorough skin examination. A complete blood count, chemistry panel, and erythrocyte sedimentation rate may be ordered to evaluate possible infections or vasculitis. Skin testing is of limited value. RAST and ELISA for serum IgE require known immunogenic epitopes for the drugs, information that is usually unavailable. In cases of hemolytic anemia, the indirect Coombs test can be used to diagnose immune-mediated destruction of red blood cells.

Studies show that 4.4% of patients whose penicillin allergy history was confirmed by a positive skin test experienced an allergic reaction to cephalosporins.13 Only 10% to 20% of patients who report a history of penicillin allergy are truly allergic when assessed by skin testing.14 Although the overall risk for a cross-allergic reaction to cephalosporins in patients with a history of a penicillin allergy is low, the use of cephalosporins requires weighing the risks versus benefits based on an informed discussion between the patient and treating physician. Table 106.1 shows the incidence of allergic reactions to penicillin.15 Some factors can transiently cause T cells to falsely identify the penicillin epitope as being allergic. For example, in up to half (50%) of patients with mononucleosis, a maculopapular rash develops after taking amoxicillin. These same patients often have no adverse drug reaction on subsequent challenge with amoxicillin at a later time. Penicillin allergy should not be diagnosed in such patients.

Treatment

Allergic Rhinitis

Oral second-generation H1 blockers (loratadine, fexofenadine), oral decongestants (pseudoephedrine), and nasal decongestants (oxymetazoline, phenylephrine) can be used for mild, intermittent symptoms.16 Moderate to severe and persistent nasal symptoms may require the addition of intranasal steroid (fluticasone, triamcinolone, budesonide), or chromone derivative such as cromoglycate and nedocromil. An intraocular antihistamine (olopatadine), intraocular chromone, or intraocular ketorolac can be used for ocular allergies, including conjunctivitis.17

Drug Allergy

The most prudent approach in managing possible drug allergy–related complaints in the ED is to discontinue use of the suspect medication or medications, treat the allergic symptoms, and prescribe a suitable alternative drug or drugs. Severe symptoms should be treated in the same way as anaphylaxis (see Box 106.8). Patients with Stevens-Johnson syndrome and toxic epidermal necrolysis require a multidisciplinary approach that includes an intensivist, burn surgeon, and endocrinologist or allergist. For minor allergic drug reactions, H1 antihistamines can be prescribed for itching, flushing, and rash. Steroids are reserved for serious or extensive drug reactions.

Follow-up, Next Steps in Care, and Patient Education

Urticaria

Epidemiology

Urticaria (hives) is a fairly common reaction that affects approximately 20% of the population at some point in their lifetime.18 It has numerous different underlying causes and consists of several different types and subtypes. Spontaneous urticaria is broadly divided into acute (<6 weeks) and chronic (≥6 weeks) forms, with the latter representing approximately 10% to 20% of cases.

Presenting Signs and Symptoms

Patients with urticaria usually have hives of variable duration and location.20,21 Urticarial lesions are pruritic, erythematous, raised rashes that blanch on palpation. The lesions are typically round or oval with serpiginous borders, but they may vary in color, size, and shape (Fig. 106.3). They may be localized or appear throughout the body, but there is a slight predilection for the trunk, hands, feet, lips, tongue, and ears. Urticaria usually starts with erythema (flare) as a result of capillary vasodilation in the superficial layer of the dermis. As the protein-rich fluid extravasates into surrounding tissue, it evolves into raised wheals and may change from red to white. A history of pruritic red rash that changes in size and shape, with extension and regression over a period of hours or days, favors the diagnosis of urticaria.

image

Fig. 106.3 Acute urticaria.

Buy Membership for Emergency Medicine Category to continue reading. Learn more here